Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lot-to-lot Consistency and Immune Persistence of Zhifei's 23-Valent Pneumococcal Vaccine
NCT06314867Phase 3Active, not recruiting
- Sponsor
- Zhifei Green Bamboo
- Start
- Jan 2023
- Primary completion
- Dec 2024
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of 23-valent pneumococcal polysaccharide vaccine in pneumococcal disease, sponsored by Zhifei Green Bamboo. Started Jan 2023; status: active, not recruiting.
02
Drugs
23-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT06314867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06314867.